No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /

No. 101 - 200 Paclitaxel Patents:

	PAT. NO.		Title
101	6,472,507		Carrier based drug delivery system
102	6,472,420		Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
103	6,471,979		Apparatus and method for delivering compounds to a living organism
104	6,471,968		Multifunctional nanodevice platform
105	6,471,943		Formulation and method for treating neoplasms by inhalation
106	6,469,186		Process for mass production of GMP paclitaxel and related taxanes
107	6,469,182		Intermediates in the preparation of macrocyclic analogs
108	6,469,050		7-hexanoyltaxol and methods for preparing the same
109	6,469,022		Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
110	6,469,004		Benzoheterocycles and their uses as MEK inhibitors
111	6,468,963		Methods and formulations for reducing toxicity associated with diabetes treatments
112	6,468,961		Gel composition and methods
113	6,468,795		Antisense modulation of Apaf-1 expression
114	6,465,625		Taxol derivatives
115	6,465,448		Methoxyamine potentiation of temozolomide anti-cancer activity
116	6,465,247		Mammalian myeloid progenitor cell subsets
117	6,464,976		Methods and compositions for reducing immune response
118	6,462,062		Compounds and methods for use thereof in the treatment of cancer or viral infections
119	6,462,041		Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
120	6,462,017		Method of reducing side effects of chemotherapy in cancer patients
121	6,461,641		Tumor delivery vehicles
122	6,461,637		Method of administering liposomal encapsulated taxane
123	6,461,602		Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
124	6,459,003		Ether compounds
125	6,458,976		Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
126	6,458,974		Synthesis of .beta.-lapachone and its intermediates
127	6,458,835		Method of inhibiting or treating chemotherapy-induced hair loss
128	6,458,799		Deazaguanine analog, preparation thereof and use thereof
129	6,458,775		NAALADase inhibitors useful as pharmaceutical compounds and compositions
130	6,458,766		Halovir, an antiviral marine natural product, and derivatives thereof
131	6,458,568		Method for the production of baccatin-III by enzymatic synthesis
132	6,458,389		Microgranules containing cisplatin
133	6,458,387		Sustained release microspheres
134	6,458,373		Emulsion vehicle for poorly soluble drugs
135	6,458,347		Drug complex
136	6,455,593		Method of dynamic retardation of cell cycle kinetics to potentiate cell damage
137	6,455,582		Sulohydroxamic acids and sulohyroxamates and their use as MEK inhibitors
138	6,455,575		Phosphonooxymethyl ethers of taxane derivatives
139	6,455,559		Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
140	6,455,280		Methods and compositions for inhibiting neoplastic cell growth
141	6,455,040		Tumor necrosis factor receptor 5
142	6,454,871		Method of cleaning passageways using a mixed phase flow of gas and a liquid
143	6,452,044		Benzenedicarboxylic acid derivatives
144	6,452,025		Three-step conversion of protected taxane ester to paclitaxel
145	6,452,024		Process for extraction and purification of paclitaxel from natural sources
146	6,451,784		Formulation and method for treating neoplasms by inhalation
147	6,451,776		Water soluble prodrugs of hindered alcohols
148	6,451,373		Method of forming a therapeutic coating onto a surface of an implantable prosthesis
149	6,451,339		Compositions and methods for improved delivery of hydrophobic agents
150	6,448,443		Synthesis of combinatorial libraries of compounds reminiscent of natural products

151	6,448,417		Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-cbz 10-deacetylbaccatin III
152	6,448,401		Process for water soluble azole compounds
153	6,448,264		Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors
154	6,448,054		Purposeful movement of human migratory cells away from an agent source
155	6,447,997		Gene coding for GADD153 as a clinical diagnostic and prognostic in cancer therapy
156	6,447,796		Sustained release hydrophobic bioactive PLGA microspheres
157	6,447,542		Implantable members for receiving therapeutically useful compositions
158	6,444,638		Combinations of PKC inhibitors and therapeutic agents for treating cancers
159	6,443,976		Methods for treating conditions and illnesses associated with abnormal vasculature
160	6,441,253		Method for the synthesis of taxanes
161	6,441,186		Epothilone analogs
162	6,441,025		Water soluble paclitaxel derivatives
163	6,441,017		Inhibitors of prenyl-protein transferase
164	6,440,966		Benzenesulfonamide derivatives and their use as MEK inhibitors
165	6,440,676		Diagnostic assay for cancer
166	6,440,393		Carbon dioxide enhancement of inhalation therapy
167	6,437,025		Poly(ethylene glycol) derivatives with proximal reactive groups
168	6,436,931		Cytotoxic agents comprising taxanes and their therapeutic use
169	6,436,684		Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
170	6,436,430		Self-emulsifying compositions for drugs poorly soluble in water
171	6,436,386		Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
172	6,433,198		Preparation of 6-.alpha.-hydroxy-7-deoxytaxanes using nocardioides luteus or a hydroxylase isolated therefrom
173	6,433,187		Certain polycyclic compounds useful as tubulin-binding agents
174	6,433,147		Death domain containing receptor-4
175	6,433,145		Keratinocyte derived interferon
176	6,433,012		Method for inhibiting inflammatory disease
177	6,432,928		Complexes and their compositions
178	6,432,639		Isolated CYP3A4 nucleic acid molecules and detection methods
179	6,429,304		Nucleic acids encoding a katanin p60 subunit
180	6,428,968		Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject
181	6,428,579		Implantable prosthetic devices coated with bioactive molecules
182	6,426,415		Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
183	6,426,076		Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy
184	6,423,753		Use of colchinol derivatives as vascular damaging agents
185	6,423,740		Chalcones having antiproliferative activity
186	6,423,736		Compounds and methods for use thereof in the treatment of cancer or viral infections
187	6,423,735		Compounds and methods for use thereof in the treatment of cancer or viral infections
188	6,423,734		Method of preventing cancer
189	6,420,591		Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection
190	6,420,411		Compounds and methods for use thereof in the treatment of cancer or viral infections
191	6,420,382		Tyrosine kinase inhibitors
192	6,420,378		Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
193	6,420,375		Fused ring compounds, process for producing the same and use thereof
194	6,420,173		Method for mass production and storage of seedlings of Eleutherococcus senticosus (Siberian ginseng) through cell culturing
195	6,420,150		Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
196	6,420,131		Use of fluorescein aryl ethers in high throughput cytochrome P450 inhibition assays
197	6,419,952		Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
198	6,419,901		Method for treating neoplasms by inhalation
199	6,419,900		Formulation and method for treating neoplasms by inhalation
200	6,419,896		Non-invasive approach for assessing tumors in living animals

No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /